IBDEI1M3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28973,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,28973,1,3,0)
 ;;=3^Zoladex, 10.8 mg total
 ;;^UTILITY(U,$J,358.3,28974,0)
 ;;=96401^^182^1844^10^^^^1
 ;;^UTILITY(U,$J,358.3,28974,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28974,1,2,0)
 ;;=2^96401
 ;;^UTILITY(U,$J,358.3,28974,1,3,0)
 ;;=3^Chemotherapy,IM/SQ
 ;;^UTILITY(U,$J,358.3,28975,0)
 ;;=96402^^182^1844^19^^^^1
 ;;^UTILITY(U,$J,358.3,28975,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28975,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,28975,1,3,0)
 ;;=3^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,28976,0)
 ;;=96372^^182^1844^1^^^^1
 ;;^UTILITY(U,$J,358.3,28976,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28976,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,28976,1,3,0)
 ;;=3^Administration of Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,28977,0)
 ;;=96374^^182^1844^18^^^^1
 ;;^UTILITY(U,$J,358.3,28977,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28977,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,28977,1,3,0)
 ;;=3^IV Push,Single Non-Chemo Drug
 ;;^UTILITY(U,$J,358.3,28978,0)
 ;;=51720^^182^1844^6^^^^1
 ;;^UTILITY(U,$J,358.3,28978,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28978,1,2,0)
 ;;=2^51720
 ;;^UTILITY(U,$J,358.3,28978,1,3,0)
 ;;=3^Bladder Instill Anticarc
 ;;^UTILITY(U,$J,358.3,28979,0)
 ;;=J0897^^182^1844^14^^^^1
 ;;^UTILITY(U,$J,358.3,28979,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28979,1,2,0)
 ;;=2^J0897
 ;;^UTILITY(U,$J,358.3,28979,1,3,0)
 ;;=3^Denosumab Inj 1 mg
 ;;^UTILITY(U,$J,358.3,28980,0)
 ;;=J1950^^182^1844^24^^^^1
 ;;^UTILITY(U,$J,358.3,28980,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28980,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,28980,1,3,0)
 ;;=3^Leuprolide Acetate Susp 3.75 mg
 ;;^UTILITY(U,$J,358.3,28981,0)
 ;;=J3489^^182^1844^34^^^^1
 ;;^UTILITY(U,$J,358.3,28981,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28981,1,2,0)
 ;;=2^J3489
 ;;^UTILITY(U,$J,358.3,28981,1,3,0)
 ;;=3^Zoledronic Acid 1 mg
 ;;^UTILITY(U,$J,358.3,28982,0)
 ;;=J3490^^182^1844^31^^^^1
 ;;^UTILITY(U,$J,358.3,28982,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28982,1,2,0)
 ;;=2^J3490
 ;;^UTILITY(U,$J,358.3,28982,1,3,0)
 ;;=3^Unclassified Biologics
 ;;^UTILITY(U,$J,358.3,28983,0)
 ;;=J9155^^182^1844^13^^^^1
 ;;^UTILITY(U,$J,358.3,28983,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28983,1,2,0)
 ;;=2^J9155
 ;;^UTILITY(U,$J,358.3,28983,1,3,0)
 ;;=3^Degarelix 1 mg
 ;;^UTILITY(U,$J,358.3,28984,0)
 ;;=J9217^^182^1844^25^^^^1
 ;;^UTILITY(U,$J,358.3,28984,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28984,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,28984,1,3,0)
 ;;=3^Leuprolide Acetate Susp 7.5 mg
 ;;^UTILITY(U,$J,358.3,28985,0)
 ;;=J9218^^182^1844^22^^^^1
 ;;^UTILITY(U,$J,358.3,28985,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28985,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,28985,1,3,0)
 ;;=3^Leuprolide Acetate 1 mg
 ;;^UTILITY(U,$J,358.3,28986,0)
 ;;=J9219^^182^1844^23^^^^1
 ;;^UTILITY(U,$J,358.3,28986,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28986,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,28986,1,3,0)
 ;;=3^Leuprolide Acetate Implant 65 mg
 ;;^UTILITY(U,$J,358.3,28987,0)
 ;;=J0270^^182^1844^2^^^^1
 ;;^UTILITY(U,$J,358.3,28987,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28987,1,2,0)
 ;;=2^J0270
 ;;^UTILITY(U,$J,358.3,28987,1,3,0)
 ;;=3^Alprostadil 1.25 mcg
 ;;^UTILITY(U,$J,358.3,28988,0)
 ;;=J0275^^182^1844^3^^^^1
 ;;^UTILITY(U,$J,358.3,28988,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28988,1,2,0)
 ;;=2^J0275
 ;;^UTILITY(U,$J,358.3,28988,1,3,0)
 ;;=3^Alprostadil Urethral Suppository
 ;;^UTILITY(U,$J,358.3,28989,0)
 ;;=J2370^^182^1844^28^^^^1
